NZ567982A - Influenza vaccines extemporaneously adsorbed to aluminium adjuvants - Google Patents
Influenza vaccines extemporaneously adsorbed to aluminium adjuvantsInfo
- Publication number
- NZ567982A NZ567982A NZ567982A NZ56798206A NZ567982A NZ 567982 A NZ567982 A NZ 567982A NZ 567982 A NZ567982 A NZ 567982A NZ 56798206 A NZ56798206 A NZ 56798206A NZ 567982 A NZ567982 A NZ 567982A
- Authority
- NZ
- New Zealand
- Prior art keywords
- component
- antigen
- extemporaneously
- adsorbed
- adjuvant
- Prior art date
Links
Abstract
Disclosed is a kit when used to prepare an immunogenic composition at the point of use or within 12 hours before use of said immunogenic composition, said kit comprising: (i) an antigen component, comprising an influenza virus antigen; and (ii) an adjuvant component, comprising an aluminium salt, wherein the antigen component and the adjuvant component are separate, and wherein the immunogenic composition is prepared by mixing of the antigen component and the adjuvant component at the point of use or within 12 hours before use. Also disclosed is a process for preparing an influenza vaccine, comprising the steps of: (i) preparing an antigen component comprising an influenza virus antigen; (ii) preparing an adjuvant component comprising an aluminium salt; and (iii) combining the antigen and adjuvant components at the point of use, or within 12 hours of use of said influenza vaccine.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2260105A | 2005-11-04 | 2005-11-04 | |
US73560505P | 2005-11-09 | 2005-11-09 | |
PCT/GB2006/004138 WO2007052060A1 (en) | 2005-11-04 | 2006-11-06 | Influenza vaccines extemporaneously adsorbed to aluminium adjuvants |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ567982A true NZ567982A (en) | 2012-10-26 |
Family
ID=47042255
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ567982A NZ567982A (en) | 2005-11-04 | 2006-11-06 | Influenza vaccines extemporaneously adsorbed to aluminium adjuvants |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ567982A (en) |
-
2006
- 2006-11-06 NZ NZ567982A patent/NZ567982A/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010008468A (en) | NUCLEIC ACIDS COMPRISING FORMULA (NuGlX<sub >mGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS. | |
WO2007052155A3 (en) | Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant | |
EA200801251A1 (en) | VACCINES AGAINST FLU ADSORBED ON ALUMINUM ADJUVANTS FOR IMMEDIATE ADMISSION | |
PL1951299T3 (en) | Influenza vaccines including combinations of particulate adjuvants and immunopotentiators | |
MY150706A (en) | Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant | |
MXPA01007760A (en) | Immunological adjuvant compound. | |
NZ592977A (en) | IgE CH3 PEPTIDE VACCINE | |
CL2011003192A1 (en) | (2s) -3- (2-fluoro-5- (5-fluoro-1h-pyrrolo [2,3-b] pyridin-3-yl) phenylamino) bicyclo [2.2.2] octane-2-carboxylic acid; method to prepare it; pharmaceutical composition comprising it; and its use in the treatment of influenza; method to reduce influenza virus in vitro. | |
EP2377551A3 (en) | Adjuvanted influenza vaccines including cytokine-inducing agents | |
NZ596870A (en) | Vaccine compositions comprising a saponin adjuvant | |
JP2011504486A5 (en) | ||
WO2007024941A3 (en) | Polyvalent vaccine | |
TW200643028A (en) | Vaccine | |
AR041880A1 (en) | IMMUNOGEN COMPOSITION | |
JP2009501901A5 (en) | ||
WO2007052059A3 (en) | Changing th1/th2 balance in split influenza vaccines with adjuvants | |
MX2009006178A (en) | Salmonella vaccine. | |
BRPI0312194B8 (en) | recombinant mononegavirales virus, recombinant measles virus, recombinant measles virus vector, rescue system, immunogenic composition and vaccine composition | |
WO2002087494A3 (en) | Novel vaccine | |
BR0010323A (en) | Immunogenic compositions, kit and method of making it for use in the immunization of a mammal | |
WO2014150822A3 (en) | Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use | |
SG160328A1 (en) | Adjuvant composition comprising aluminium phosphate and 3d-mpl | |
WO2006067635A3 (en) | USE OF Ϝδ T LYMPHOCYTE ACTIVATORS AS VACCINE ADJUVANT | |
MX2007002659A (en) | Vaccine composition against hepatitis c virus. | |
AU2001284354A1 (en) | Immunological adjuvant compounds, compositions, and methods of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 06 NOV 2013 BY FB RICE Effective date: 20130205 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 06 NOV 2016 BY CPA GLOBAL Effective date: 20131003 |
|
ASS | Change of ownership |
Owner name: NOVARTIS VACCINES AND DIAGNOSTICS LIMITED, GB Effective date: 20160128 |
|
LAPS | Patent lapsed |